Andrew Alexis, MD, MPH: The State of Atopic Dermatitis MD Magazine
The second big advancement is dupilumab, which is an injectable biologic agent for atopic dermatitis
. Now this one is approved for moderate to severe atopic dermatitis
, that we're talking about, [but] a more severe population than the topical that I ...